Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Williams Companies Inc (WMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Williams Companies Inc — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Williams Companies Inc trades at $72.43 (market cap $87.41B). The key difference: Williams Companies Inc is far larger — about 51.1× Nuvation Bio Inc. Class A Common Stock's market cap, and Williams Companies Inc pays a 2.94% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Williams Companies Inc for 58 Days on average.
| NUVB | WMB | |
|---|---|---|
Market Cap | $1.71B | $87.41B |
Volume | 5,448,712 | 5,173,332 |
Sector | Health | Energy |
52-Week High | $9.54 | $79.40 |
52-Week Low | $3.41 | $56.51 |
Typical Hold Time | 0 Days | 58 Days |
Enterprise Value | $1.30B | $118.03B |
Dividend Yield | — | 2.94% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Williams Companies (WMB) trades at $72.34, down 0.07% with a bullish technical signal and strong analyst support. The stock shows robust fundamentals with 25.18% net income margin and 24.02% ROE, supported by stable cash flows from operations of $5.90B. Recent earnings show mixed results with Q1 2026 beating expectations while Q2 2026 slightly missed. The company benefits from growing natural gas demand driven by AI data center expansion and maintains a strategic position in midstream energy infrastructure.
WMB presents a compelling investment case with 79% analyst buy ratings and $87.27 consensus price target offering 21% upside. Key opportunities include dividend growth strategy and exposure to AI-powered energy demand, while risks involve energy market volatility and high debt levels of $24.74B long-term debt. The stock's valuation at 28.47 P/E appears justified by strong profitability and growth prospects in natural gas infrastructure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Williams Companies Inc
Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →
